Person

Kevin Hourican

Chair and CEO · Director, Sysco

Current S&P 500 boards
2
Current roles
2
Open-market buys
$0
Open-market sales
$13.2M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

  • CVS
    CVS Health
    EVP & President, CVS Pharmacy
    Jun 2018 – last filing Apr 2019

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Oct 24, 2022SYYSale75,019$81.22$6.1M
Apr 8, 2022SYYSale75,018$86.00$6.5M
Aug 27, 2018CVSSale8,564$75.00$642K

SEC reporting-owner ID (CIK) 1741853 · all filings on EDGAR